Resnick, Chodorow & Associates was responsible for the systematic literature review, abstract review, and evidence synthesis for an ISTH clinical practice guideline for antithrombotic treatment in COVID-19.
Click here to read the practice guideline.
Resnick, Chodorow & Associates wrote a white paper on nonalcoholic fatty liver disease for the National Committee for Quality Assurance. Click here to read the white paper.
Resnick, Chodorow & Associates was responsible for the systematic literature review, abstract review, and evidence synthesis for a Cystic Fibrosis Foundation clinical practice guideline on treatment of sinonasal disease among people with cystic fibrosis. Click here to read the practice guideline.
Resnick, Chodorow & Associates wrote a white paper on COVID-19 vaccine hesitancy to support efforts of the GTMRx Institute's National Taskforce on Building Vaccine Confidence in the Medical Neighborhood.
Click here to read the report.
Resnick, Chodorow & Associates wrote a white paper on quality of care for patients with type 2 diabetes and heart failure for the National Committee for Quality Assurance. Click here to read the report.
Resnick, Chodorow & Associates researched and wrote issue briefs for the Patient Access Network Foundation on the topic of cost-sharing for prescription medications. Click here to read the briefs.
Resnick, Chodorow & Associates wrote a proceedings report on health equity for women and birthing people for the Association of American Medical Colleges Center for Health Justice. Click here to read the report.
Resnick, Chodorow & Associates was responsible for the systematic literature review and meta analysis for a Cystic Fibrosis Foundation clinical practice guideline on CFTR modulators. Click here to read the guideline.
Resnick, Chodorow & Associates wrote a white paper for PhRMA on disparities in medication access and adherence. Click here to read the white paper.
Resnick, Chodorow & Associates provided methodologic expertise on a systematic review of the literature on microscopic hematuria screening for the American Urogynecologic Society. Click here to read the review.
Resnick, Chodorow & Associates supported the American Academy of Otolaryngic Allergy to produce an evidence review of clinical trial data that led to regulatory approval of biologic agents for treatment of conditions that are relevant to otolaryngology and allergy.
Click here to read the review.
Resnick, Chodorow & Associates wrote a meeting summary on public trust in science for the National Academies of Science, Engineering, and Medicine. Click here to read the proceedings report.
Copyright © 2018 Resnick, Chodorow & Associates - All Rights Reserved.